We are live on
!
Find out more
KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$360M
1-Year Est. Return
16.9%
This Fund
S&P 500
This Quarter
Est. Return
+1.32%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$502M
AUM Growth
+$38.7M
(+8.3%)
Cap. Flow
+$35.5M
Cap. Flow
% of AUM
7.08%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
145
New
16
Increased
39
Reduced
29
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unum
UNM
|
+$13.4M |
| 2 |
Enovis
ENOV
|
+$12.6M |
| 3 |
Aflac
AFL
|
+$3.92M |
| 4 |
Qualcomm
QCOM
|
+$2.08M |
| 5 |
3M
MMM
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$7.31M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$3.07M |
| 3 |
Apple
AAPL
|
+$1.29M |
| 4 |
Elevance Health
ELV
|
+$913K |
| 5 |
Cisco
CSCO
|
+$810K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.41% |
| 2 | Technology | 17.31% |
| 3 | Financials | 15% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVNS
126
DELISTED
Avanos Medical
AVNS
| $10K | ﹤0.01% |
224
| – | – |
|
127
Baxter International
BAX
$14.3B
| $10K | ﹤0.01% |
276
| – | – |
|
128
Hershey
HSY
$36.4B
| $10K | ﹤0.01% |
109
| – | – |
|
129
Wells Fargo
WFC
$265B
| $10K | ﹤0.01% |
170
| – | – |
|
130
Cardinal Health
CAH
$56.5B
| $8K | ﹤0.01% |
93
| – | – |
|
131
Dollar General
DG
$26.9B
| $6K | ﹤0.01% |
75
| – | – |
|
|
PC
132
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
| $6K | ﹤0.01% |
465
| – | – |
|
133
iShares Silver Trust
SLV
$31.7B
| $5K | ﹤0.01% |
300
| – | – |
|
|
DD
134
DELISTED
Du Pont De Nemours E I
DD
| $4K | ﹤0.01% |
58
| – | – |
|
135
AT&T
T
$166B
| $3K | ﹤0.01% |
107
| – | – |
|
136
Jefferies Financial Group
JEF
$12.7B
| $1K | ﹤0.01% |
29
| – | – |
|
137
Nokia
NOK
$52.8B
| $1K | ﹤0.01% |
150
| – | – |
|
138
Zimmer Biomet
ZBH
$18.7B
| $1K | ﹤0.01% |
8
| – | – |
|
139
Becton Dickinson
BDX
$49B
| $0 | ﹤0.01% |
3
| – | – |
|
|
RSH
140
DELISTED
RADIOSHACK CORP
RSH
| $0 | ﹤0.01% |
1,000
| – | – |
|
|
ATVI
141
DELISTED
Activision Blizzard
ATVI
| $0 | ﹤0.01% |
+6
| New | +$146 |
|
|
FRP
142
DELISTED
FAIRPOINT COMMUNICATIONS INC.
FRP
| $0 | ﹤0.01% |
75
| – | – |
|
Similar funds
NC
RIP
LSC
5VM
NI
RA
SWM
HCM
Kelly Lawrence W & Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Kelly Lawrence W & Associates held 145 positions worth $502M, up 8.3% from $463M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Kelly Lawrence W & Associates deployed $35.5M of net new capital in Q2 2015, opening 16 new positions and adding to 39 existing holdings. Its largest new stake was Enovis: 148,437 shares worth $11.8M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Viatris, an estimated $7.31M trimmed.
- Kelly Lawrence W & Associates's largest Q2 2015 buy was Enovis: 148,437 shares worth $11.8M.
- Kelly Lawrence W & Associates added most to Unum in Q2 2015, an estimated $13.4M increase.
- Kelly Lawrence W & Associates's biggest Q2 2015 reduction was Viatris, cutting an estimated $7.31M.
- Kelly Lawrence W & Associates's ten largest holdings make up 35% of its $502M portfolio in Q2 2015.
- Kelly Lawrence W & Associates opened 16 new positions and closed 0 in Q2 2015.
- Kelly Lawrence W & Associates's portfolio value rose 8.3% quarter-over-quarter to $502M.
Based on Kelly Lawrence W & Associates's 13F filing for Q2 2015, filed 13 Aug 2015.